Rejuvenation of the skin surface: chemical peel and dermabrasion.
Chemical peel and dermabrasion are traditional, well-proven methods for the rejuvenation of the skin. The medium-depth trichloroacetic acid peel and the deep phenol peel offer distinct advantages and disadvantages and are discussed in detail in this article. The management of complications associated with both peel techniques is also discussed. Regional dermabrasion is an effective adjunct to facial rejuvenative surgery, such as face lift and blepharoplasty. Full-face dermabrasion and spot or local dermabrasion are most often used in the treatment of facial scarring. The technique of dermabrasion is discussed as well as its indications and postoperative care. Results are shown for both dermabrasion and peel.
Branham
G H
GH
Department of Otolaryngology-Head and Neck Surgery, Saint Louis University School of Medicine, MO 63110-0250, USA.
Thomas
J R
JR
D000287:Administration, Topical; D002615:Chemexfoliation / Q000009:adverse effects / Q000379:methods*; D017439:Cicatrix, Hypertrophic / Q000209:etiology; D003869:Dermabrasion / Q000009:adverse effects / Q000379:methods*; D062109:Dermatologic Surgical Procedures; D004338:Drug Combinations; D000431:Ethanol / Q000008:administration & dosage / Q000627:therapeutic use; D005145:Face / Q000601:surgery*; D006561:Herpes Simplex / Q000209:etiology; D006801:Humans; D017495:Hyperpigmentation / Q000209:etiology; D007641:Keratolytic Agents / Q000008:administration & dosage* / Q000009:adverse effects / Q000627:therapeutic use; D019344:Lactic Acid / Q000008:administration & dosage / Q000627:therapeutic use; D018579:Patient Selection; D010636:Phenols / Q000008:administration & dosage* / Q000009:adverse effects / Q000627:therapeutic use; D012060:Rejuvenation; D012118:Resorcinols / Q000008:administration & dosage / Q000627:therapeutic use; D012459:Salicylates / Q000008:administration & dosage / Q000627:therapeutic use; D012867:Skin / Q000187:drug effects; D015595:Skin Aging; D014238:Trichloroacetic Acid / Q000008:administration & dosage* / Q000009:adverse effects / Q000627:therapeutic use; D014775:Virus Activation
D004338:Drug Combinations; C061170:Jessner's solution; D007641:Keratolytic Agents; D010636:Phenols; D012118:Resorcinols; D012459:Salicylates; D019344:Lactic Acid; D000431:Ethanol; D014238:Trichloroacetic Acid